Diabetes and obesity - Issue 38/2019
Editorial
71
Reviews
75
Gut microbiome in children and risk of developing type 1 diabetes mellitus
Uboš Ambro, Anna Kamlárová, René Link, Ivana Lukáčová, Alojz Bo, Oliver Rácz
90
Vliv léčby inzulinem Fiasp na glykemie, HbA1c a tělesnou hmotnost u osob s diabetem 1. a 2. typu: studie z reálné praxe
Rudolf Chlup, Jana Zapletalová, Hana Zálešáková, Johana Kochtová, Richard Kaňa
98
103
Adipocytokines as possible etiopathogenetic mechanisms leading to a higher incidence of autoimmune thyroiditis in patients with type 2 diabetes mellitus
Štefan Sotak, Zbynek Schroner, Ivica Lazúrová, Marek Felš Ci, Darina Petrášová, Izabela Bertková, Miriam Mitníková, Jozefína Petrovičová
110
Management of arterial hypertension in persons with type 2 diabetes mellitus
Udovít Gašpar, Slavomíra Filipová
Clinical studies
115
118
121
Intensive glycemic compensation and prevention of chronic diabetic complications
Vladimír Uličiansky
Case studies
127
129
131
Combination of basal insulin and metformin: a case report
Radovan Plášil
News
134
55. výročný kongres European Association for the Study of Diabetes
Peter Novodvorský, MUDr. Marta Korecová
136
140
79. konferencia American Diabetes Association
Viera Doničová
Diabetes and obesity
2019 Číslo 38
Najčítanejšie v tomto čísle
- Vliv léčby inzulinem Fiasp na glykemie, HbA1c a tělesnou hmotnost u osob s diabetem 1. a 2. typu: studie z reálné praxe
- Has everything really been discovered about SGLT2 inhibitors?
- Early insulin treatment of a newly diagnosed type 2 diabetic patient: a case report
- Gut microbiome in children and risk of developing type 1 diabetes mellitus